SCHEMBL7964323

SCHEMBL7964323

c1cnc2ccc(OC[C@@H]3CO3)cc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
TP53 P04637 4/20 0.57
TSHR P16473 4/20 0.57
HIF1A Q16665 2/20 0.57
CYP3A4 P08684 2/20 0.57
TDP1 Q9NUW8 1/20 0.50
FGFR1 P11362 1/20 0.48
SRC P12931 1/20 0.48
RAB9A P51151 4/20 0.47
MAPT P10636 6/20 0.46
NPC1 O15118 2/20 0.46
HTT P42858 2/20 0.46
NR2F2 P24468 1/20 0.46
MAPK1 P28482 1/20 0.46
POLB P06746 1/20 0.45
LMNA P02545 3/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3266069 1.00 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2TP53TSHRHIF1A
SCHEMBL3266066 1.00 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2TP53TSHRHIF1A
SCHEMBL7966245 0.88 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2TP53TSHRHIF1A
SCHEMBL7966244 0.88 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2TP53TSHRHIF1A
SCHEMBL7966243 0.88 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2TP53TSHRHIF1A
SCHEMBL10366380 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TP53TSHRRAB9A
SCHEMBL10368025 0.82 RAB9A (0.47) ALDH1A1SMN1; SMN2RAB9AMAPTNPC1
SCHEMBL844653 0.81 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2TP53TSHRHIF1A
SCHEMBL30546900 0.81 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2TP53TSHRHIF1A
SCHEMBL4620895 0.81 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2TP53TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed